Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.
about
Management of hepatitis C in patients with chronic kidney disease.HIV and HCV Medications in End-Stage Renal Disease.Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.Hepatitis C and its impact on renal transplantation.Liver Support With Albumin Dialysis Reduces Hepatitis C Virus Viremia and Facilitates Antiviral Treatment of Severe Hepatitis C Virus Recurrence After Liver Transplantation.Pegylated Interferon Mono-Therapy of Chronic Hepatitis C in the Dialysis Population: Systematic Review and Meta-Analysis.Therapy of hepatitis C by direct-acting anti-virals: the end of HCV in dialysis population?Current treatment status and barriers for patients with chronic HCV infection in mainland China: A national multicenter cross-sectional survey in 56 hospitals.Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease - a nationwide cohort study.Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment.Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (HCV) infection in patients with severe renal impairment: A multicentre experience.Cost-effectiveness of elbasvir/grazoprevir use in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and chronic kidney disease in the United States.Direct-acting antiviral agent efficacy and safety in renal transplant recipients with chronic hepatitis C virus infection: A PRISMA-compliant study.Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents.Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation.Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis.Chronic kidney disease: Treatment of hepatitis C virus infection in patients with CKD.Single nucleotide polymorphisms near IL28B gene and response to treatment of chronic hepatitis C in hemodialysis patients.Hepatitis C infection in renal transplantation: pathogenesis, current impact and emerging trends.Direct-acting Antiviral Agents in Hepatitis C Virus-infected Renal Allograft Recipients: Treatment and Outcome Experience from Single Center.Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation.Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.Hepatitis C and renal transplantation in era of new antiviral agents
P2860
Q34932338-B8F568A2-5441-4CDF-B413-D17FAA9D7A57Q35832564-2C0FC1CB-2D90-45F7-AC51-97CDBE877525Q36220536-1ADA71F3-27CB-47C6-AD49-B8C7F4BD29F8Q38341218-46BDB628-C121-4D77-AB23-6EB124D7881BQ38439220-708F2EED-E928-43BE-A490-EB5EBFDC5B60Q38551615-DA0F1200-E8C6-40EF-8905-DC8897CE8EDAQ38586088-5ED8FC8B-DF60-446B-8470-5F4FF55FCB22Q38611469-E881C2CF-2D72-43D4-A8CE-610AEFBFF46EQ38621703-B1490503-5BF8-4D5E-90BF-44B13FDE9690Q39067369-C6FA962D-05C0-4ADB-B3FD-44135A8ADEE8Q39092977-9405BC5B-2D2F-46B3-B56D-8420813C67F5Q39099569-22D2CBDE-E283-4011-A082-1634879710D6Q39102936-4D8BE6EF-561D-43EA-9A45-43DF3E0372C2Q40107697-0F9C785A-715E-4805-823F-03E41014DFF8Q40278284-51B3F836-499F-484B-80E5-3A67BCABBE29Q40297644-7BC159DA-A82E-4375-8929-D17ECB7D13DFQ40707781-07671DA8-67F8-49F7-837D-DAB39CE82049Q40900678-C36EBA4A-EB6D-4BF9-AC0E-C52C161C3C0FQ41601725-B5B0C819-EDEE-49DA-877F-7F8479F4C061Q47559302-179A7D30-A12C-4B36-84DD-06AFEE0B9F6EQ55353924-91F0FE0F-BD56-4330-A8B4-05C1E72453CCQ55389831-2844069D-17AF-4C3E-BEA7-E4ADA6824303Q55501318-4974282A-6D22-43BA-85F3-9BBE35E4668AQ58792851-031137FA-85C9-48A2-BB8A-9C54E55ADA5B
P2860
Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Antiviral therapy (pegylated i ...... -analysis of clinical studies.
@en
type
label
Antiviral therapy (pegylated i ...... -analysis of clinical studies.
@en
prefLabel
Antiviral therapy (pegylated i ...... -analysis of clinical studies.
@en
P2093
P2860
P356
P1476
Antiviral therapy (pegylated i ...... -analysis of clinical studies.
@en
P2093
P2860
P304
P356
10.1111/JVH.12276
P577
2014-07-16T00:00:00Z